Remote Oncology AI Researcher - Clinical Trials Expert

Alignerr Corp.; France; À distance; EUR 83 000 - 152 000; Temps partiel

Résumé du poste

Alignerr seeks an Oncology Clinical Researcher to help shape how AI training reasons about cancer trials. This remote hourly contract is built for clinicians and researchers who can contribute on their own schedule.

You will design trial protocols, analyze clinical data, ensure regulatory alignment with FDA/EMA, and assess AI-generated oncology content for accuracy. Flexible hours, freelance autonomy, and potential for ongoing collaboration.

Qualifications

• Experience in designing and managing oncology clinical trials from protocol development through data readout.
• Strong background in analyzing oncology clinical data including endpoints and biomarkers.
• Familiar with FDA/EMA regulatory submission standards.
• Detail-oriented and able to work independently on structured tasks.

Responsabilités

• Design and evaluate oncology clinical trial protocols — study design, enrollment frameworks, and regulatory/ethical compliance.
• Analyze cancer trial data across safety, efficacy, and biomarker endpoints to assess treatment performance.
• Translate trial outcomes into regulatory-grade narratives aligned with FDA/EMA submission standards.
• Review and evaluate AI-generated oncology content for scientific and regulatory accuracy.
• Help shape how frontier AI systems understand and communicate oncology concepts.
• Work independently and asynchronously — fully on your own schedule.

Connaissances

Oncology trials

Data analysis

Regulatory standards

Independent work

Description du poste

Alignerr seeks an Oncology Clinical Researcher to help shape how AI training reasons about cancer trials. This remote hourly contract is built for clinicians and researchers who can contribute on their own schedule.

You will design trial protocols, analyze clinical data, ensure regulatory alignment with FDA/EMA, and assess AI-generated oncology content for accuracy. Flexible hours, freelance autonomy, and potential for ongoing collaboration.